Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1 metallo β-lactamase by five Gram-negative bacilli: Survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 3, 2003, Pages 631-638

  Yamasaki, Katsutoshi ^a   Komatsu, Masaru ^b   Yamashita, Tomonari ^c   Shimakawa, Koichi ^b   Ura, Toshiro ^d   Nishio, Hisaaki ^e   Satoh, Kaori ^f   Washidu, Ryoudou ^c   Kinoshita, Shohiro ^g   Aihara, Masanori ^b  

^a WAKAYAMA ROSAI HOSPITAL   (Japan)

^b TENRI HOSPITAL   (Japan)

^c FALCO Biosystems Ltd   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e Shiga Medical Center for Adults   (Japan)

^f KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 MERCAPTOPROPIONIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE; CEFMETAZOLE; CEFOPERAZONE; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN; SULPERAZON; SULTAMICILLIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL LABORATORY; CONTROLLED STUDY; DNA SEQUENCE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EPIDEMIC; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; HOSPITAL; HOSPITAL INFECTION; ISOELECTRIC FOCUSING; JAPAN; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MEDICAL RESEARCH; MOLECULAR ECOLOGY; MONITORING; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; SPECIES;

BETA-LACTAMASES; CROSS INFECTION; GRAM-NEGATIVE BACTERIA; HEALTH SURVEYS; HUMANS; JAPAN; LABORATORIES, HOSPITAL;

EID: 0037342876     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg103     Document Type: Article

References (41)

1. Ishii, Y., Ohno, A., Taguchi, H., Imajo, S., Ishiguro, M. & Matsuzawa, H. (1995). Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrobial Agents and Chemotherapy 39, 2269-75.
2. Yagi, T., Kurokawa, H., Senda, K., Ichiyama, S., Ito, H., Ohsuka, S. et al. (1997). Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like β-lactamase genes. Antimicrobial Agents and Chemotherapy 41, 2606-11.
3. Ma, L., Ishii, Y., Ishiguro, M., Matsuzawa, H. & Yamaguchi, K. (1998). Cloning and sequencing of the gene encoding Toho-2, a class A β-lactamase preferentially inhibited by tazobactam. Antimicrobial Agents and Chemotherapy 42, 1181-6.
4. Yagi, T., Kurokawa, H., Shibata, N., Shibayama, K. & Arakawa, Y. (2000). A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiology Letters 184, 53-6.
5. Komatsu, M., Ikeda, N., Aihara, M., Nakamachi, Y., Kinoshita, S., Yamasaki, K. et al. (2001). Hospital outbreak of MEN-1-derived extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Journal of Infection and Chemotherapy 7, 94-101.
6. Watanabe, M., Iyobe, S., Inoue, M. & Mitsuhashi, S. (1991). Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 35, 147-51.
7. Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H. et al. (1994). Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrobial Agents and Chemotherapy 38, 71-8.
8. IMP among clinically isolated strains of Serratia marcescens. Antimicrobial Agents and Chemotherapy 39, 824-9.
9. Minami, S., Akama, M., Araki, H., Watanabe, Y., Narita, H., Iyobe, S. et al. (1996). Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B β-lactamase. Journal of Antimicrobial Chemotherapy 37, 433-44.
10. Senda, K., Arakawa, Y., Nakashima, K., Ito, H., Ichiyama, S., Shimokata, K. et al. (1996). Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrobial Agents and Chemotherapy 40, 349-53.
11. IMP) in Gram-negative rods resistant to broad-spectrum β-lactams. Journal of Clinical Microbiology 34, 2909-13.
12. IMP. Antimicrobial Agents and Chemotherapy 42, 2006-11.
13. Takahashi, A., Yomoda, S., Kobayashi, I., Okubo, T., Tsunoda, M. & Iyobe, S. (2000). Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. Journal of Clinical Microbiology 38, 526-9.
14. National Committee for Clinical Laboratory Standards. (1999). Performance Standard for Antimicrobial Susceptibility Testing: Ninth Informational Supplement; Tentative Standard M100-S9. NCCLS, Wayne, PA, USA.
15. Tzouvelekis, L. S., Tzelepi, E., Tassios, P. T. & Legakis, N. J. (2000). CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. International Journal of Antimicrobial Agents 14, 137-42.
16. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA, USA.
17. Jarlier, V., Nicolas, M.-H., Fournier, G. & Philippon, A. (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 10, 867-78.
18. Tzelepi, E., Giakkoupi, P., Sofianou, D., Loukova, V., Kemeroglou, A. & Tsakris, A. (2000). Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. Journal of Clinical Microbiology 38, 542-6.
19. National Committee for Clinical Laboratory Standards. (1997). Performance Standards for Antimicrobial Disk Susceptibility Tests-Sixth Edition: Approved Standard M2-A6. NCCLS, Villanova, PA, USA.
20. Arakawa, Y., Shibata, N., Shibayama, K., Kurokawa, H., Yagi, T., Fujiwara, H. et al. (2000). Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds. Journal of Clinical Microbiology 38, 40-3.
21. Sanders, C. C., Sanders, W. E., Jr & Moland, E. S. (1986). Characterization of β-lactamases in situ on polyacrylamide gels. Antimicrobial Agents and Chemotherapy 30, 951-2.
22. Komatsu, M., Aihara, M., Shimakawa, K., Yamanaka, T. & Matsuo, T. (2000). Detection of extended-spectrum β-lactamases producing Enterobacteriaceae in feces [in Japanese]. Kansenshogaku Zasshi 74, 250-8.
23. Arlet, G. & Philippon, A. (1991). Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB). FEMS Microbiology Letters 82, 19-26.
24. Gniadkowski, M., Schneider, I., Palucha, A., Jungwirth, R., Mikiewicz, B. & Bauernfeind, A. (1998). Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrobial Agents and Chemotherapy 42, 827-32.
25. Sabaté M., Tarragó, R., Navarro, F., Mirò, E., Vergés, C., Barbé, J. et al. (2000). Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrobial Agents and Chemotherapy 44, 1970-3.
26. Steward, C. D., Rasheed, J. K., Hubert, S. K., Biddle, J. W., Raney, P. M., Anderson, G. J. et al. (2001). Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β-lactamase detection methods. Journal of Clinical Microbiology 39, 2864-72.
27. Rasheed, J. K., Jay, C., Metchock, B., Berkowitz, F., Weigel, L., Steward, C. et al. (1997). Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrobial Agents and Chemotherapy 41, 647-53.
28. Yan, J.-J., Hsueh, P.-R., Ko, W.-C., Luh, K.-T., Tsai, S.-H., Wu, H.-M. et al. (2001). Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrobial Agents and Chemotherapy 45, 2224-8.
29. Kurokawa, H., Yagi, T., Shibata, N., Shibayama, K. & Arakawa, Y. (1999). Worldwide proliferation of carbapenem-resistant Gram-negative bacteria. Lancet 354, 955.
30. Nordmann, P. (1998). Trend in β-lactam resistance among Enterobacteriaceae. Clinical Infectious Diseases 27, Suppl. 1, S100-10.
31. Horii, T., Arakawa, Y., Ohta, M., Ichiyama, S., Wacharotayankun, R. & Kato, N. (1993). Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrobial Agents and Chemotherapy 37, 984-90.
32. Tzouvelekis, L. S., Tzelepi, E., Prinarakis, E., Gazouli, M., Katrahoura, A., Giakkoupi, P. et al. (1998). Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals. Journal of Clinical Microbiology 36, 266-8.
33. Woodford, N., Palepou, M. F., Babini, G. S., Bates, J. & Livermore, D. M. (1998). Carbapenemase-producing Pseudomonas aeruginosa in UK. Lancet 352, 546-7.
34. Cornaglia, G., Riccio, M.-L., Mazzariol, A., Lauretti, L., Fontana, R. & Rossolini, G. M. (1999). Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 353, 899-900.
35. Koh, T. H., Babini, G. S., Woodford, N., Sng, L.-H., Hall, L. M. & Livermore, D. M. (1999). Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore. Lancet 353, 2162.
36. Cardoso, O., Sousa, J. C., Leito, R. & Peixe, L. (1999). Carbapenem-hydrolysing β-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal. Journal of Antimicrobial Chemotherapy 44, 135.
37. Hibbert-Rogers, L. C. F., Heritage, J., Gascoyne-Binzi, D. M., Hawkey, P. M., Todd, N., Lewis, I. J. et al. (1995). Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. Journal of Antimicrobial Chemotherapy 36, 65-82.
38. Chanal, C., Sirot, D., Romaszko, J. P., Bret, L. & Sirot, J. (1996). Survey of prevalence of extended-spectrum β-lactamases among Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 38, 127-32.
39. Arpin, C., Coze, C., Rogues, A. M., Gachie, J. P., Bebear, C. & Quentin, C. (1996). Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. Journal of Clinical Microbiology 34, 2163-9.
40. Neuwirth, C., Siebor, E., Lopez, J., Pechinot, A. & Kazmierczak, A. (1996). Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Entero-bacteriaceae. Journal of Clinical Microbiology 34, 76-9.
41. Luzzaro, F., Perilli, M., Migliavacca, R., Lombardi, G., Micheletti, P., Agodi, A. et al. (1998). Repeated epidemics caused by extended-spectrum β-lactamase-producing Serratia marcescens strains. European Journal of Clinical Microbiology and Infectious Diseases 17, 629-36.